BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37705976)

  • 1. Identification of immunodominant T cell epitopes induced by natural Zika virus infection.
    Eickhoff CS; Meza KA; Terry FE; Colbert CG; Blazevic A; Gutiérrez AH; Stone ET; Brien JD; Pinto AK; El Sahly HM; Mulligan MJ; Rouphael N; Alcaide ML; Tomashek KM; Focht C; Martin WD; Moise L; De Groot AS; Hoft DF
    Front Immunol; 2023; 14():1247876. PubMed ID: 37705976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools.
    Antonelli ACB; Almeida VP; de Castro FOF; Silva JM; Pfrimer IAH; Cunha-Neto E; Maranhão AQ; Brígido MM; Resende RO; Bocca AL; Fonseca SG
    Sci Rep; 2022 Jan; 12(1):53. PubMed ID: 34997041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombination of B- and T-cell epitope-rich loci from Aedes- and Culex-borne flaviviruses shapes Zika virus epidemiology.
    Gaunt MW; Gubler DJ; Pettersson JH; Kuno G; Wilder-Smith A; de Lamballerie X; Gould EA; Falconar AK
    Antiviral Res; 2020 Feb; 174():104676. PubMed ID: 31837392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel ZIKV vaccine comprised of immunodominant CD4+ and CD8+ T cell epitopes identified through comprehensive epitope mapping in Zika virus infected mice.
    Sun J; Zheng Z; Li M; Liu Z; Su X; Jin X
    Vaccine; 2021 Aug; 39(36):5173-5186. PubMed ID: 34353682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8
    Huang H; Li S; Zhang Y; Han X; Jia B; Liu H; Liu D; Tan S; Wang Q; Bi Y; Liu WJ; Hou B; Gao GF; Zhang F
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prior Dengue Virus Exposure Shapes T Cell Immunity to Zika Virus in Humans.
    Grifoni A; Pham J; Sidney J; O'Rourke PH; Paul S; Peters B; Martini SR; de Silva AD; Ricciardi MJ; Magnani DM; Silveira CGT; Maestri A; Costa PR; de-Oliveira-Pinto LM; de Azeredo EL; Damasco PV; Phillips E; Mallal S; de Silva AM; Collins M; Durbin A; Diehl SA; Cerpas C; Balmaseda A; Kuan G; Coloma J; Harris E; Crowe JE; Stone M; Norris PJ; Busch M; Vivanco-Cid H; Cox J; Graham BS; Ledgerwood JE; Turtle L; Solomon T; Kallas EG; Watkins DI; Weiskopf D; Sette A
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978707
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Lopes-Ribeiro Á; Araujo FP; Oliveira PM; Teixeira LA; Ferreira GM; Lourenço AA; Dias LCC; Teixeira CW; Retes HM; Lopes ÉN; Versiani AF; Barbosa-Stancioli EF; da Fonseca FG; Martins-Filho OA; Tsuji M; Peruhype-Magalhães V; Coelho-Dos-Reis JGA
    Front Immunol; 2022; 13():1035515. PubMed ID: 36466864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8
    Wen J; Tang WW; Sheets N; Ellison J; Sette A; Kim K; Shresta S
    Nat Microbiol; 2017 Mar; 2():17036. PubMed ID: 28288094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-existing T Cell Memory against Zika Virus.
    Schouest B; Grifoni A; Pham J; Mateus J; Sydney J; Brien JD; De Silva AD; Balmaseda A; Harris E; Sette A; Weiskopf D
    J Virol; 2021 May; 95(12):. PubMed ID: 33789994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From ZikV genome to vaccine: in silico approach for the epitope-based peptide vaccine against Zika virus envelope glycoprotein.
    Alam A; Ali S; Ahamad S; Malik MZ; Ishrat R
    Immunology; 2016 Dec; 149(4):386-399. PubMed ID: 27485738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses.
    Reynolds CJ; Suleyman OM; Ortega-Prieto AM; Skelton JK; Bonnesoeur P; Blohm A; Carregaro V; Silva JS; James EA; Maillère B; Dorner M; Boyton RJ; Altmann DM
    Sci Rep; 2018 Jan; 8(1):672. PubMed ID: 29330423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Influence on the Dominance of Virus-Specific CD4 T Cell Epitopes in Zika Virus Infection.
    Koblischke M; Stiasny K; Aberle SW; Malafa S; Tsouchnikas G; Schwaiger J; Kundi M; Heinz FX; Aberle JH
    Front Immunol; 2018; 9():1196. PubMed ID: 29899743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zika Virus Subgenomic Flavivirus RNA Generation Requires Cooperativity between Duplicated RNA Structures That Are Essential for Productive Infection in Human Cells.
    Pallarés HM; Costa Navarro GS; Villordo SM; Merwaiss F; de Borba L; Gonzalez Lopez Ledesma MM; Ojeda DS; Henrion-Lacritick A; Morales MA; Fabri C; Saleh MC; Gamarnik AV
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32581095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Immune Responses Against Zika Virus After Sequential Dengue and Zika Virus Infection in Humans.
    Delgado FG; Torres KI; Castellanos JE; Romero-Sánchez C; Simon-Lorière E; Sakuntabhai A; Roth C
    Viruses; 2018 Sep; 10(9):. PubMed ID: 30205518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD8+ and CD4+ T Cell Immunogen Atlas of Zika Virus Reveals E, NS1 and NS4 Proteins as the Vaccine Targets.
    Zhang H; Xiao W; Zhao M; Zhao Y; Zhang Y; Lu D; Lu S; Zhang Q; Peng W; Shu L; Zhang J; Liu S; Zong K; Wang P; Ye B; Li S; Tan S; Zhang F; Zhou J; Liu P; Wu G; Lu X; Gao GF; Liu WJ
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of Zika virus-specific T cells from seropositive and virus-naïve donors for potential use as an autologous or "off-the-shelf" immunotherapeutic.
    Hanajiri R; Sani GM; Hanley PJ; Silveira CG; Kallas EG; Keller MD; Bollard CM
    Cytotherapy; 2019 Aug; 21(8):840-855. PubMed ID: 31279695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural infection by Zika virus but not DNA vaccination consistently elicits antibodies that compete with two potently neutralising monoclonal antibodies targeting distinct epitopes.
    Smith TC; Espinoza DO; Zhu Y; Cardona-Ospina JA; Bowman NM; Becker-Dreps S; Rouphael N; Rodriguez-Morales AJ; Bucardo F; Edupuganti S; Premkumar L; Mulligan MJ; de Silva AM; Collins MH
    EBioMedicine; 2023 Dec; 98():104875. PubMed ID: 37983984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immuno-informatics-based Identification of Novel Potential B Cell and T Cell Epitopes to Fight Zika Virus Infections.
    Ezzemani W; Windisch MP; Kettani A; Altawalah H; Nourlil J; Benjelloun S; Ezzikouri S
    Infect Disord Drug Targets; 2021; 21(4):572-581. PubMed ID: 32778040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational prediction and analysis of potential antigenic CTL epitopes in Zika virus: A first step towards vaccine development.
    Dikhit MR; Ansari MY; Vijaymahantesh ; Kalyani ; Mansuri R; Sahoo BR; Dehury B; Amit A; Topno RK; Sahoo GC; Ali V; Bimal S; Das P
    Infect Genet Evol; 2016 Nov; 45():187-197. PubMed ID: 27590716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-Reactivity and Anti-viral Function of Dengue Capsid and NS3-Specific Memory T Cells Toward Zika Virus.
    Lim MQ; Kumaran EAP; Tan HC; Lye DC; Leo YS; Ooi EE; MacAry PA; Bertoletti A; Rivino L
    Front Immunol; 2018; 9():2225. PubMed ID: 30327651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.